Umesh Modi is a chartered accountant, and Pamini Jatheeskumar is a chartered certified accountant at Silver Levene...
  Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead...
Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead pharmacist, Health and Wellbeing Directorate, Public Health England
More inWhite Papers  

ReadyWrapMarch 29 2016

Activa is launching a new compression wrap for patients with oedema, venous and lymphatic disease.

Available from May, the product is intended for use on limbs, with the range including products designed for use on the foot, calf, knee or thigh and for gauntlet and full arm length. Fabric colours are black and sand.

“The wraps aim to improve patients’ quality of life by preventing swelling from building up in limbs, improving mobility, reducing the risk of reoccurrence and ensuring easy application using a colour coded system,” said Activa.

Its chronic oedema trainers will provide full education and technical support. Information on the ReadyWrap range, new order forms and sizing charts for both arm and leg garments will be available from local Activa representatives and on the Activa website from May 1. A seven-day delivery service will be available through Credenhill, partner and maker of Activa’s made-to-measure hosiery.

Deborah Young, Senior Product Manager at Activa Healthcare, commented: “We have added ReadyWrap to our compression range after consultation with nurses who have requested products that empower patients and improve treatment outcomes. We’re looking forward to supporting both patients and clinicians and anticipate an increased concordance with compression therapy thanks in part to the simple application method.”

For more information, Activa’s Customer Care Advisors can be contacted on 08450 606707.


Activa announcement

July 31 2018 General practices employing pharmacists are citing improved capacity to see patients and workload changes as the main benefits of the scheme.
July 25 2018 Switching to sulfonylureas in type 2 diabetes has been linked with an increased risk of complications compared with staying on metformin, a BMJ study has concluded. However, the study has...